# Pharmacokinetic Analysis of Cefiderocol in Patients With Acute Burn Injuries

> **NCT07465432** · PHASE4 · RECRUITING · sponsor: **University of Tennessee** · enrollment: 12 (estimated)

## Conditions studied

- Drug Clearance After Severe Burn Injury

## Interventions

- **DRUG:** Cefiderocol

## Key facts

- **NCT ID:** NCT07465432
- **Lead sponsor:** University of Tennessee
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-16
- **Primary completion:** 2027-02-28
- **Final completion:** 2027-02-28
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-03-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07465432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07465432, "Pharmacokinetic Analysis of Cefiderocol in Patients With Acute Burn Injuries". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07465432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*